368 related articles for article (PubMed ID: 19195626)
1. Insulin resistance and steatosis in humans.
Capeau J
Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
[TBL] [Abstract][Full Text] [Related]
2. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
3. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
Larter CZ; Chitturi S; Heydet D; Farrell GC
J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
[TBL] [Abstract][Full Text] [Related]
4. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
[TBL] [Abstract][Full Text] [Related]
5. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
6. Role of mitochondria in non-alcoholic fatty liver disease.
Pessayre D
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S20-7. PubMed ID: 17567459
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.
Roden M
Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):335-48. PubMed ID: 16932311
[TBL] [Abstract][Full Text] [Related]
8. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production.
Grefhorst A; Hoekstra J; Derks TG; Ouwens DM; Baller JF; Havinga R; Havekes LM; Romijn JA; Kuipers F
Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G592-8. PubMed ID: 15817811
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
Serfaty L; Capeau J
Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic steatohepatitis and metabolic syndrome.
Machado M; Cortez-Pinto H
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
[TBL] [Abstract][Full Text] [Related]
11. Free fatty acids and insulin resistance.
Delarue J; Magnan C
Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):142-8. PubMed ID: 17285001
[TBL] [Abstract][Full Text] [Related]
12. [Insulin signaling: mechanisms altered in insulin resistance].
Capeau J
Med Sci (Paris); 2005 Dec; 21 Spec No():34-9. PubMed ID: 16598903
[TBL] [Abstract][Full Text] [Related]
13. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Parekh S; Anania FA
Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
[TBL] [Abstract][Full Text] [Related]
14. [Insulin resistance].
Tamura Y; Kawamori R
Nihon Rinsho; 2006 Jun; 64(6):1071-4. PubMed ID: 16768111
[TBL] [Abstract][Full Text] [Related]
15. The role of the lipogenic pathway in the development of hepatic steatosis.
Postic C; Girard J
Diabetes Metab; 2008 Dec; 34(6 Pt 2):643-8. PubMed ID: 19195625
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.
Luyckx FH; Lefebvre PJ; Scheen AJ
Diabetes Metab; 2000 Apr; 26(2):98-106. PubMed ID: 10804323
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
[TBL] [Abstract][Full Text] [Related]
18. Role of ChREBP in hepatic steatosis and insulin resistance.
Denechaud PD; Dentin R; Girard J; Postic C
FEBS Lett; 2008 Jan; 582(1):68-73. PubMed ID: 17716660
[TBL] [Abstract][Full Text] [Related]
19. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity.
Samane S; Christon R; Dombrowski L; Turcotte S; Charrouf Z; Lavigne C; Levy E; Bachelard H; Amarouch H; Marette A; Haddad PS
Metabolism; 2009 Jul; 58(7):909-19. PubMed ID: 19394055
[TBL] [Abstract][Full Text] [Related]
20. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
Cusi K
Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]